— Know what they know.
Not Investment Advice
Also trades as: BDMS-R.BK (SET) · $vol 41M · BDMS.BK (SET) · $vol 40M · BDULF (OTC) · $vol 0M · BDUUF (OTC) · $vol 0M

BDUUY OTC

Bangkok Dusit Medical Services Public Company Limited
1W: +0.0% 1M: +1.9% 3M: -0.5% YTD: -4.5% 1Y: -27.9% 3Y: -18.4% 5Y: +12.0%
$23.30
+0.00 (+0.00%)
 
OTC · Healthcare · Medical - Care Facilities · Tech Score Buy · Power 64 · $9.3B mcap · 321M float · 0.0000% daily turnover · Short 82% of daily vol

Cash Flow Trends

Operating Cash Flow
$22.5B -2.1% ▼
5Y CAGR: +14.0%
Capital Expenditures
$10.0B +14.5% ▲
5Y CAGR: +8.5%
Free Cash Flow
$12.5B +10.8% ▲
5Y CAGR: +19.9%
Dividends Paid
$11.4B -2.7% ▼
Buybacks
$0 +0.0% ▲
Net Change in Cash
-$472M -11.8% ▼

Cash Flow Composition

Year-over-Year Growth

View Full Cash Flow Statement
Line ItemFY2021FY2022FY2023FY2024FY2025
— Operating Activities —
Net Income$10.6B$16.5B$18.7B$20.3B$15.2B
Depreciation & Amort.$6.3B$5.9B$5.8B$6.1B$6.6B
Stock-Based Comp.$0$0$0$0$0
Change in Working Capital-$349M-$138M-$728M-$231M-$914M
Other Non-Cash Items-$2.0B-$2.0B-$3.0B-$3.3B$1.6B
Operating Cash Flow$14.6B$20.3B$20.8B$23.0B$22.5B
— Investing Activities —
Capital Expenditures-$4.4B-$5.1B-$7.7B-$10.7B-$10.9B
Acquisitions (Net)$21M$863K$0$0$364M
Investment Purchases-$493M-$1.1B-$84M-$206M-$221M
Investment Sales$20M$233M$719M$385M$428M
Other Investing$60M$52M-$643M-$834M$32
Investing Cash Flow-$4.8B-$5.9B-$7.8B-$11.4B-$10.3B
— Financing Activities —
Net Debt Issuance-$5.6B-$2.7B-$6.9B-$558M-$959M
Stock Repurchased$0$0$0$0$0
Dividends Paid-$12.7B-$7.9B-$10.3B-$11.1B-$11.4B
Other Financing-$187M-$2.0B-$687M-$292M-$742M
Financing Cash Flow-$18.5B-$12.6B-$17.9B-$12.0B-$13.1B
Net Change in Cash-$8.7B$1.7B-$4.9B-$422M-$472M
Cash End of Period$10.9B$12.7B$7.8B$7.4B$6.3B
Free Cash Flow$10.2B$15.2B$12.5B$11.3B$12.5B

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms